NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-174-2019-0-US-04 A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA US National Stage 17/766,015 Pending
NHGRI E-175-2019-0-US-04 Synthetic Genes For The Treatment Propionic Acidemia (PA) Caused By Mutations In Propionyl-coA Carboxylase Beta (PCCB) US National Stage 17/766,067 Pending
NHLBI E-143-2021-2-US-01 Transmural Refinement Of Inner Curvature Charge Concentration Device For Tissue Laceration US CIP 17/710,149 Pending
NCI E-233-2014-0-EP-10 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation EP DIV 22166152.3 Pending
NEI E-227-2018-0-EP-07 Druggable Taraget to Treat Retinal Degeneration EP National Stage 20780525.0 Pending
NIAID E-233-2017-0-US-06 ASSAY FOR THE DETECTION OF ALPHA-SYNUCLEIN SEEDING ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES US CON 17/708,560 Pending
NCI E-021-2015-0-EP-36 Anti-CD70 Chimeric Antigen Receptors EP DIV 22164990.8 Pending
NCATS E-060-2017-3-US-03 Compositions And Methods For Identifying And Treating Dystonia Disorders US CON 17/706,461 Pending
NCI E-022-2017-0-US-10 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US CON 17/703,005 Issued
NEI E-227-2018-0-AU-03 Druggable Taraget to Treat Retinal Degeneration AU National Stage 2020346064 Pending
NIDDK E-086-2022-0-US-01 METHOD AND SYSTEM FOR SYNCHRONIZING A ROTATIONAL ECCENTRIC MASS WITH A MAGNETIC RESONANCE ELASTOGRAPHY SCAN US ORD 17/702,212 11821972 Issued PDF
NCI E-065-2021-0-PCT-02 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF PCT PCT PCT/US2022/021545
NIDDK E-138-2017-0-CN-19 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS CN DIV 202210281874.3 Pending
NIDDK E-001-2022-0-US-01 MOTOR FOR A MR ELASTOGRAPHY TRANSDUCER US ORD 17/697,492 11852704 Issued PDF
NCI E-097-2021-0-PCT-02 FLUOROGENIC CYANINE CARBAMATES PCT PCT PCT/US2022/020708 Expired
NCI E-042-2014-0-US-33 CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US CON 17/696,249 Pending
NIAID E-081-2013-4-JP-21 Prefusion RSV F Proteins And Their Use JP DIV 2022-041006 Pending
NCATS E-039-2021-0-PCT-02 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION PCT PCT PCT/US22/20596 Expired
NEI E-227-2018-0-ZA-14 Druggable Target to Treat Retinal Degeneration ZA National Stage 2022/03100 Pending
NCI E-111-2021-0-PCT-02 CANCER VACCINE AND METHOD OF USE THEREOF PCT PCT PCT/US2022/020165 Expired
NCI E-042-2014-0-IL-34 Chimeric Antigen Receptors Targeting CD-19 IL DIV 1992-12-29 Pending
NCI E-182-2019-2-US-07 RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER US National Stage 17/692,978 Pending
NIAID E-029-2007-0-US-05 RECOMBINANT VIRUS WITH DIMINISHED LATENCY AND METHODS OF USING SAME US DIV 17/692,540 Pending
NCI E-181-2017-0-US-23 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US DIV 17/692,787 Pending
NEI E-227-2018-0-US-13 DRUGGABLE TARGET TO TREAT RETINAL DEGENERATION US National Stage 17/642,610 Pending
NEI E-227-2018-0-MX-12 Druggable Taraget to Treat Retinal Degeneration MX National Stage MX/a/2022/003027 Pending
NEI E-227-2018-0-JP-10 Druggable Taraget to Treat Retinal Degeneration JP National Stage 2022-516237 Pending
NEI E-227-2018-0-CA-05 Druggable Taraget to Treat Retinal Degeneration CA National Stage 3151011 Pending
NEI E-227-2018-0-BR-04 Druggable Taraget to Treat Retinal Degeneration BR National Stage BR112022004515-8 Pending
NCI E-266-2011-0-US-61 T CELL RECEPTORS RECOGNIZING HLA-A1-RESTRICTED MAGE-A3 US CON 17/691,569 Pending
NCI E-030-2022-0-US-02 Anti-Viral Compositions And Methods Of Making And Using US National Stage 17/641,264 Pending
NCI E-133-2016-0-US-10 FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME US CON 17/689,698 Pending
NHLBI E-121-2016-2-US-10 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHODS OF USE US DIV 17/688,435 Pending
NIAID E-257-2015-0-US-04 COMPOUNDS FOR MODULATING FC-EPSILON-RI-BETA EXPRESSION AND USES THEREOF US DIV 17/688,618 Pending
NIDDK E-043-2020-0-EP-01 RNA Target Enrichment or Depletion of Biological Supplies EP National Stage 21763708.1 Pending
NIDDK E-043-2020-0-CA-01 RNA Target Enrichment or Depletion of Biological Supplies CA National Stage 3174707 Pending
NIDDK E-043-2020-0-JP-01 RNA Target Enrichment or Depletion of Biological Supplies JP National Stage 2022-553079 Pending
NICHD E-058-2021-0-PCT-02 La Protein As A Novel Regulator Of Osteoclastogenesis PCT PCT PCT/US2022/018639 Expired
NIDA E-053-2016-1-US-32 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF US DIV 17/685,709 Pending
NIAID E-216-2014-0-JP-16 RECOMBINANT RS VIRUS STRAINS WITH MUTATIONS IN M2-2 ORF PROVIDING RANGE OF ATTENUATION PHENOTYPE JP DIV 2022-030778 Issued
NIDA E-057-2021-0-PCT-02 DUAL-TARGET MU OPIOID AND DOPAMINE D3 RECEPTORS LIGANDS; PREPARATION AND USE THEREOF PCT PCT PCT/US2022/018287 Expired
NCATS E-101-2017-0-US-06 SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS US DIV 17/682,654 11795177 Issued PDF
NCI E-296-2011-0-US-07 METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY US DIV 17/682,655 Issued
NCI E-230-2012-0-KR-69 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 KR DIV 10-2022-7006700 Issued
NIAID E-048-2020-0-US-03 COMPOSITIONS INCLUDING IGG Fe MUTATIONS AND USES THEREOF US National Stage 17/638,139 Pending
NCATS E-072-2021-0-PCT-02 FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE PCT PCT PCT/US2022/017248 Expired
NCI E-040-2012-0-KR-69 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 2022-7005825 Pending
NIAID E-045-2021-0-PCT-02 COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE PCT PCT PCT/US2022/070744 Expired
NIAMS E-244-2020-0-PCT-02 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 PCT PCT PCT/US2022/016986 Expired
NLM E-107-2010-2-US-36 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/675,502 Pending